Research Associate on project under BNT MPCB Fund in ICTM
The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002. Under the World Bank TEQIP programme, the Maharashtra government granted it full autonomy in June 2004. Due to the recommendations of the Government of Maharashtra and University of Mumbai, the ICT was granted Deemed University Status by the MHRD on 12th September, 2008, with all provisions of the UGC for funding and support as the state owned deemed university.
Applications are invited fbr the post of Research Associate on project under BNT MPCB Fund" with Professor B. N. Thorat, chemical Engineering Department


Established in 2005, Cian Health Care Pvt. Ltd. is an emerging pharmaceutical company based at Pune, Maharashtra, India. Cian means Commitment, Innovation, Aspiration & Nurturing Relationships. Cian is a WHO-GMP & ISO-9001:2008 certified transnational manufacturing company with a wide range of pharmaceutical, nutraceutical and food supplement products. Cian has a full fledged R & D and regulatory department. Cian has its own manufacturing facility at Roorkee (Uttarakhand) and is being upgraded as per U.K. MHRA norms, and one more plant is under development in Wai (Mahashatra). Cian has developed more than 300 formulations and 500 brands for domestic market under 12 different strategic business units (SBU). Cian is in process of rapid expansion of its global business and has registered and in process of registering around 200 molecules globally, also looking forward to register more innovative molecules in next two years, covering South East Asia, C.I.S., African and Latin American Countries.
